2014: Another Year of Research Progress in Multiple Myeloma

After several years of developments in multiple myeloma treatment, 2014 continued.

An investigational new class of drugs, the anti-CD38 monoclonal antibodies, could be the next major advance in the treatment of multiple myeloma and researchers continue to explore optimizing combination therapy and maintenance therapy.

CancerConnect News coverage of advances in the management of multiple myeloma included the following key developments:

2014 FDA News in Multiple Myeloma

2014 Newly Diagnosed Multiple Myeloma News

2014 Multiple Myeloma Maintenance Therapy News

2014Relapsed/Refractory Multiple Myeloma News

2014 CancerConnect Community News

2014 Long-term Side Effects News

Copyright © 2018 CancerConnect. All Rights Reserved.